abstract gray background

Archives: Resources

PPD | Brochure
Comprehensive services for neuroscience trials

Explore imaging, cardiac safety, eCOA and adjudication services that support high-quality endpoint data in neuroscience clinical trials.

Read brochure
PPD | Webinar
GLP-1 agonist development: endpoint strategies to help differentiate your drug webinar replay

Discover endpoint strategies for GLP-1 trials, including FDA guidance, clinical adjudication and imaging approaches for drug differentiation.

Read More
PPD | Case Study
Clario delivers study setup in 10 weeks for a global chronic weight management study

Discover how rapid eCOA setup supported study timelines, site readiness and enrollment in a global Phase III chronic weight management trial.

Read More
PPD | Webinar
AI applications in neuroscience drug development

Discover how AI-enabled tools support neuroscience trials through vocal biomarkers, rater training and imaging analysis.

Read More
PPD | Brochure
FDA guidance on weight management drug trials

Explore key FDA guidance takeaways for weight management trials, including efficacy endpoints, COAs and patient-centered differentiation.

Read brochure
PPD | White Paper
Empowering Successful Transitions to Mixed FSP/FSO Model Outsourcing Partnerships

Learn how mixed FSP/FSO outsourcing models improve agility, scalability and operational efficiency in clinical development partnerships.

Get the white paper
PPD | Webinar
Unlocking the power of primary care in chronic disease research

Learn how primary care physicians can expand chronic disease trial access, improve retention and support real-world insight

Read More
PPD | Video
Respiratory disease therapeutic experts video series
  • External Link

Accelerate your trial with the support of our expert team, providing extensive global experience in planning, implementing, and delivering Phase I-IV respiratory clinical trials.

Watch the video series
PPD | White Paper
How FSP pharmacovigilance and regulatory affairs solutions facilitate new market entry

Discover how FSP pharmacovigilance and regulatory affairs support new market entry, reduce MAA risk and compliance gaps.

Get the white paper